-
Electronic (PDF)
-
Site License
-
Enterprisewide
Europe In Vitro Diagnostics Investment Opportunities, Analysis and Forecasts to 2015
Global Markets Direct, December 2009, Pages: 224
This report is an essential source for in-depth information and data relating to Europe In vitro diagnostics market. It also offers detailed and comprehensive coverage of market revenue, distribution and company share information; and the latest news, financial deals and pipeline products information of each of the key sub-segments of the in vitro diagnostics market in Europe
Scope
- The report provides information on the European in vitro diagnostics market, broken down into detailed categories and segments including In Vitro Diagnostics Devices, Clinical Chemistry Test Reagents, Immunochemistry Test Reagents, Blood Test Reagents, Microbiology Test Reagents, Infectious Immunology Test Reagents, Genetic Test Reagents, Self Testing, and Instruments.
- Market shares of all the key competitors including F. Hoffmann-La Roche Ltd., Abbott Laboratories, Beckman Coulter, Inc., and Siemens Medical Solutions, amongst others.
- Key pipeline products that are set to shape the market, broken down by sector.
- Information on the top medical equipment companies in the sector in the country covering business description, strategic analysis.
- Healthcare structure, regulatory environment, approval process, pricing trends and reimbursement.
- Product and brand updates, strategy changes, R&D projects, corporate expansions and contractions and regulatory changes.
- Key mergers and acquisitions, partnerships, private equity investments and IPOs.
- Customer, hospitals and physicians data.
Reasons to buy
- Gain a strong understanding of the in vitro diagnostics devices market in Europe.
- Evaluate and compare the attractiveness of the market in the region.
- Identify growth segments and opportunities in each industry sector within the region.
- Evaluate the pipeline of key products that will change the sector, and identify threats and opportunities before the products are launched in the region.
- Analyze the competitiveness of the market in the region and identify hotspots.
- Develop strategies based on the latest product, brand, expansion and research and development news in the region.
- Do deals with an understanding of how competitors are financed, and the mergers and partnerships that have shaped the market in the region.
- Identify and analyze the strengths and weaknesses of the industry incumbents in the region.
1 TOC
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 What Is This Report About?
3 Definitions of the Markets Covered in the Report
3.1 In Vitro Diagnostics
3.2 Clinical Chemistry
3.3 Genetic Testing
3.4 Haematology
3.5 Histology And Cytology
3.6 Immuno Chemistry
3.7 Infectious Immunology
3.8 Microbiology Culture
4 In Vitro Diagnostics in Europe
4.1 In Vitro Diagnostics, Europe, Overall Revenue ($ mn), 2000-2015
4.2 In Vitro Diagnostics, Europe, Company share (2007-2008)
5 In Vitro Diagnostics In Germany
5.1 In Vitro Diagnostics, Germany, Overall Revenue ($ mn), 2000-2015
5.2 In Vitro Diagnostics, Germany, Distribution Share (2007-2008)
5.2.1 Clinical Chemistry Distribution Share (2007-2008)
5.2.2 Genetic Testing Distribution Share (2007-2008)
5.2.3 Haematology Distribution Share (2007-2008)
5.2.4 Histology And Cytology Distribution Share (2007-2008)
5.2.5 Immuno Chemistry Distribution Share (2007-2008)
5.2.6 Infectious Immunology Distribution Share (2007-2008)
5.2.7 Microbiology Culture Distribution Share (2007-2008)
5.3 In Vitro Diagnostics, Germany, Company Share (2007-2008)
5.3.1 In Vitro Diagnostics, Germany, Company Share (2007-2008)
5.3.2 Clinical Chemistry, Germany, Company Share (2007-2008)
5.3.3 Genetic Testing, Germany, Company Share (2007-2008)
5.3.4 Haematology, Germany, Company Share (2007-2008)
5.3.5 Histology And Cytology, Germany, Company Share (2007-2008)
5.3.6 Immuno Chemistry, Germany, Company Share (2007-2008)
5.3.7 Infectious Immunology, Germany, Company Share (2007-2008)
5.3.8 Microbiology Culture, Germany, Company Share (2007-2008)
6 In Vitro Diagnostics In France
6.1 In Vitro Diagnostics, France, Overall Revenue ($ mn), 2000-2015
6.2 In Vitro Diagnostics, France, Distribution Share (2007-2008)
6.2.1 Clinical Chemistry Distribution Share (2007-2008)
6.2.2 Genetic Testing Distribution Share (2007-2008)
6.2.3 Haematology Distribution Share (2007-2008)
6.2.4 Histology And Cytology Distribution Share (2007-2008)
6.2.5 Immuno Chemistry Distribution Share (2007-2008)
6.2.6 Infectious Immunology Distribution Share (2007-2008)
6.2.7 Microbiology Culture Distribution Share (2007-2008)
6.3 In Vitro Diagnostics, France, Company Share (2007-2008)
6.3.1 In Vitro Diagnostics, France, Company Share (2007-2008)
6.3.2 Clinical Chemistry, France, Company Share (2007-2008)
6.3.3 Genetic Testing, France, Company Share (2007-2008)
6.3.4 Haematology, France, Company Share (2007-2008)
6.3.5 Histology And Cytology, France, Company Share (2007-2008)
6.3.6 Immuno Chemistry, France, Company Share (2007-2008)
6.3.7 Infectious Immunology, France, Company Share (2007-2008)
6.3.8 Microbiology Culture, France, Company Share (2007-2008)
7 In Vitro Diagnostics In United Kingdom
7.1 In Vitro Diagnostics, United Kingdom, Overall Revenue ($ mn), 2000-2015
7.2 In Vitro Diagnostics, United Kingdom, Distribution Share (2007-2008)
7.2.1 Clinical Chemistry Distribution Share (2007-2008)
7.2.2 Genetic Testing Distribution Share (2007-2008)
7.2.3 Haematology Distribution Share (2007-2008)
7.2.4 Histology And Cytology Distribution Share (2007-2008)
7.2.5 Immuno Chemistry Distribution Share (2007-2008)
7.2.6 Infectious Immunology Distribution Share (2007-2008)
7.2.7 Microbiology Culture Distribution Share (2007-2008)
7.3 In Vitro Diagnostics, United Kingdom, Company Share (2007-2008)
7.3.1 In Vitro Diagnostics, United Kingdom, Company Share (2007-2008)
7.3.2 Clinical Chemistry, United Kingdom, Company Share (2007-2008)
7.3.3 Genetic Testing, United Kingdom, Company Share (2007-2008)
7.3.4 Haematology, United Kingdom, Company Share (2007-2008)
7.3.5 Histology And Cytology, United Kingdom, Company Share (2007-2008)
7.3.6 Immuno Chemistry, United Kingdom, Company Share (2007-2008)
7.3.7 Infectious Immunology, United Kingdom, Company Share (2007-2008)
7.3.8 Microbiology Culture, United Kingdom, Company Share (2007-2008)
8 In Vitro Diagnostics In Italy
8.1 In Vitro Diagnostics, Italy, Overall Revenue ($ mn), 2000-2015
8.2 In Vitro Diagnostics, Italy, Distribution Share (2007-2008)
8.2.1 Clinical Chemistry Distribution Share (2007-2008)
8.2.2 Genetic Testing Distribution Share (2007-2008)
8.2.3 Haematology Distribution Share (2007-2008)
8.2.4 Histology And Cytology Distribution Share (2007-2008)
8.2.5 Immuno Chemistry Distribution Share (2007-2008)
8.2.6 Infectious Immunology Distribution Share (2007-2008)
8.2.7 Microbiology Culture Distribution Share (2007-2008)
8.3 In Vitro Diagnostics, Italy, Company Share (2007-2008)
8.3.1 In Vitro Diagnostics, Italy, Company Share (2007-2008)
8.3.2 Clinical Chemistry, Italy, Company Share (2007-2008)
8.3.3 Genetic Testing, Italy, Company Share (2007-2008)
8.3.4 Haematology, Italy, Company Share (2007-2008)
8.3.5 Histology And Cytology, Italy, Company Share (2007-2008)
8.3.6 Immuno Chemistry, Italy, Company Share (2007-2008)
8.3.7 Infectious Immunology, Italy, Company Share (2007-2008)
8.3.8 Microbiology Culture, Italy, Company Share (2007-2008)
9 In Vitro Diagnostics In Spain
9.1 In Vitro Diagnostics, Spain, Overall Revenue ($ mn), 2000-2015
9.2 In Vitro Diagnostics, Spain, Distribution Share (2007-2008)
9.2.1 Clinical Chemistry Distribution Share (2007-2008)
9.2.2 Genetic Testing Distribution Share (2007-2008)
9.2.3 Haematology Distribution Share (2007-2008)
9.2.4 Histology And Cytology Distribution Share (2007-2008)
9.2.5 Immuno Chemistry Distribution Share (2007-2008)
9.2.6 Infectious Immunology Distribution Share (2007-2008)
9.2.7 Microbiology Culture Distribution Share (2007-2008)
9.3 In Vitro Diagnostics, Spain, Company Share (2007-2008)
9.3.1 In Vitro Diagnostics, Spain, Company Share (2007-2008)
9.3.2 Clinical Chemistry, Spain, Company Share (2007-2008)
9.3.3 Genetic Testing, Spain, Company Share (2007-2008)
9.3.4 Haematology, Spain, Company Share (2007-2008)
9.3.5 Histology And Cytology, Spain, Company Share (2007-2008)
9.3.6 Immuno Chemistry, Spain, Company Share (2007-2008)
9.3.7 Infectious Immunology, Spain, Company Share (2007-2008)
9.3.8 Microbiology Culture, Spain, Company Share (2007-2008)
10 In Vitro Diagnostics In Netherlands
10.1 In Vitro Diagnostics, Netherlands, Overall Revenue ($ mn), 2000-2015
10.2 In Vitro Diagnostics, Netherlands, Distribution Share (2007-2008)
10.2.1 Clinical Chemistry Distribution Share (2007-2008)
10.2.2 Genetic Testing Distribution Share (2007-2008)
10.2.3 Haematology Distribution Share (2007-2008)
10.2.4 Histology And Cytology Distribution Share (2007-2008)
10.2.5 Immuno Chemistry Distribution Share (2007-2008)
10.2.6 Infectious Immunology Distribution Share (2007-2008)
10.2.7 Microbiology Culture Distribution Share (2007-2008)
10.3 In Vitro Diagnostics, Netherlands, Company Share (2007-2008)
10.3.1 In Vitro Diagnostics, Netherlands, Company Share (2007-2008)
10.3.2 Clinical Chemistry, Netherlands, Company Share (2007-2008)
10.3.3 Genetic Testing, Netherlands, Company Share (2007-2008)
10.3.4 Haematology, Netherlands, Company Share (2007-2008)
10.3.5 Histology And Cytology, Netherlands, Company Share (2007-2008)
10.3.6 Immuno Chemistry, Netherlands, Company Share (2007-2008)
10.3.7 Infectious Immunology, Netherlands, Company Share (2007-2008)
10.3.8 Microbiology Culture, Netherlands, Company Share (2007-2008)
11 In Vitro Diagnostics In Belgium
11.1 In Vitro Diagnostics, Belgium, Overall Revenue ($ mn), 2000-2015
11.2 In Vitro Diagnostics, Belgium, Distribution Share (2007-2008)
11.2.1 Clinical Chemistry Distribution Share (2007-2008)
11.2.2 Genetic Testing Distribution Share (2007-2008)
11.2.3 Haematology Distribution Share (2007-2008)
11.2.4 Histology And Cytology Distribution Share (2007-2008)
11.2.5 Immuno Chemistry Distribution Share (2007-2008)
11.2.6 Infectious Immunology Distribution Share (2007-2008)
11.2.7 Microbiology Culture Distribution Share (2007-2008)
11.3 In Vitro Diagnostics, Belgium, Company Share (2007-2008)
11.3.1 In Vitro Diagnostics, Belgium, Company Share (2007-2008)
11.3.2 Clinical Chemistry, Belgium, Company Share (2007-2008)
11.3.3 Genetic Testing, Belgium, Company Share (2007-2008)
11.3.4 Haematology, Belgium, Company Share (2007-2008)
11.3.5 Histology And Cytology, Belgium, Company Share (2007-2008)
11.3.6 Immuno Chemistry, Belgium, Company Share (2007-2008)
11.3.7 Infectious Immunology, Belgium, Company Share (2007-2008)
11.3.8 Microbiology Culture, Belgium, Company Share (2007-2008)
12 Overview of Key Companies in Europe In Vitro Diagnostics Market
12.1 Ventana Medical Systems, Inc
12.1.1 Company Overview
12.2 Sysmex Corporation
12.2.1 Company Overview
12.2.2 Sysmex Corporation Pipeline Products
12.3 Siemens Healthcare
12.3.1 Company Overview
12.4 Qiagen N.V
12.4.1 Company Overview
12.4.2 Qiagen N.V. Pipeline Products
12.5 Phadia AB
12.5.1 Company Overview
12.5.2 Phadia AB Pipeline Products
12.6 Ortho-Clinical Diagnostics Inc
12.6.1 Company Overview
12.6.2 Ortho-Clinical Diagnostics Inc. Pipeline Products
12.7 Mindray Medical International Limited
12.7.1 Company Overview
12.7.2 Mindray Medical International Limited Pipeline Products
12.8 Inverness Medical Innovations, Inc
12.8.1 Company Overview
12.8.2 Inverness Medical Innovations, Inc. Pipeline Products
12.9 Hologic, Inc
12.9.1 Company Overview
12.9.2 Hologic, Inc. Pipeline Products
12.10 Gen-Probe Incorporated
12.10.1 Company Overview
12.10.2 Gen-Probe Incorporated Pipeline Products
12.11 F. Hoffmann-La Roche Ltd
12.11.1 Company Overview
12.12 Digene Corporation
12.12.1 Company Overview
12.13 Dade Behring Holdings, Inc
12.13.1 Company Overview
12.14 DiaSorin S.p.A
12.14.1 Company Overview
12.14.2 DiaSorin S.p.A Pipeline Products
12.15 Bio-Rad Laboratories, Inc
12.15.1 Company Overview
12.16 bioMerieux S.A
12.16.1 Company Overview
12.16.2 Biomerieux Sa Pipeline Products
12.17 Becton, Dickinson and Company
12.17.1 Company Overview
12.17.2 Becton, Dickinson and Company Pipeline Products
12.18 Beckman Coulter, Inc
12.18.1 Company Overview
12.18.2 Beckman Coulter, Inc. Pipeline Products
12.19 Abbott Laboratories
12.19.1 Company Overview
12.19.2 Abbott Laboratories Pipeline Products
13 Financial Deals Landscape
13.1 Acquisition
13.1.1 Lab21 Acquires Delphic Diagnostic From BDO
13.1.2 International SOS Acquires Majority Stake In Abermed
13.1.3 Bio-Rad Laboratories To Acquire Medical Diagnostics Segment From Biotest
13.1.4 ERBA DIAGNOSTICS MANNHEIM Acquires PLIVA-Lachema Diagnostika
13.1.5 Thermo Fisher Scientific Completes Acquisition Of B.R.A.H.M.S
13.1.6 QIAGEN Completes Acquisition Of DxS
13.2 Private Equity
13.2.1 Legal & General Ventures To Sell LGC
13.2.2 LinkMed To Acquire 51% Stake In AbSorber From Koncentra And Jan Holgersson
13.2.3 North Atlantic Value Completes Acquisition Of Celsis International
13.2.4 The Riverside Acquires Crioestaminal Saude e Tecnologia
13.3 Venture Financing
13.3.1 Curetis Secures $27.89 Million In Series A Round Of Financing
13.3.2 Biomedical Diagnostics Secures $4.52 Million In Financing
13.3.3 Pronota Secures Additional $1.92 Million In Series B Round Of Financing
13.3.4 Biocartis Secures $14.9 Million In Series A Equity Round Of Financing
13.3.5 mtm laboratories Secures $10.21 Million In Fourth Tranche Of Series C Financing Round
13.3.6 Kreatech Diagnostics Secures $2.86 Million In Financing Round
13.3.7 Agendia Raises $23 Million In Series E Financing
13.4 Equity Offerings
13.4.1 ExonHit Therapeutics Plans Rights Issue Of New Shares For $25.67 Million
13.4.2 Osmetech Announces Private Placement Of Shares For $16.3 Million
13.4.3 Mediwatch Completes Private Placement Of $0.57 Million
13.4.4 QIAGEN Completes Private Placement Of Its Common Stock For $640 Million
13.5 Partnerships
13.5.1 HairDX Enters Into Distribution Agreement With Svenson Haar Studios
13.5.2 MabCure Signs Research Agreement With AZ Sint-Lucas
14 APPENDIX
14.1 Global Markets Direct Research Methodology
14.2 Secondary Research
14.3 Primary Research
14.4 Models
14.5 Forecasts
14.6 Expert Panel Validation
14.7 Currency Conversion
14.8 Contact Us
14.9 Disclaimer
1.1 List of Tables
Table 1: In Vitro Diagnostics, Europe, Overall Revenue ($ mn), 2000-2015
Table 2: Europe In Vitro Diagnostics Market, Cross-Category Analysis, 2000-2015
Table 3: In Vitro Diagnostics, Europe, Overall Revenue ($ mn), Historic, 2000-2008
Table 4: In Vitro Diagnostics, Europe, Overall Revenue ($ mn), Forecast, 2008-2015
Table 5: In Vitro Diagnostics, Europe, Company share by Revenue ($ mn), 2007-2008
Table 6: In Vitro Diagnostics, Germany, Overall Revenue ($ mn), 2000-2015
Table 7: In Vitro Diagnostics, Germany, Overall Revenue ($ mn), Historic, 2000-2008
Table 8: In Vitro Diagnostics, Germany, Overall Revenue ($ mn), Forecast, 2008-2015
Table 9: Clinical Chemistry, Germany, Distribution Share by Revenue ($mn), 2007-2008
Table 10: Genetic Testing, Germany, Distribution Share by Revenue ($mn), 2007-2008
Table 11: Haematology, Germany, Distribution Share by Revenue ($mn), 2007-2008
Table 12: Histology And Cytology, Germany, Distribution Share by Revenue ($mn), 2007-2008
Table 13: Immuno Chemistry, Germany, Distribution Share by Revenue ($mn), 2007-2008
Table 14: Infectious Immunology, Germany, Distribution Share by Revenue ($mn), 2007-2008
Table 15: Microbiology Culture, Germany, Distribution Share by Revenue ($mn), 2007-2008
Table 16: In Vitro Diagnostics, Germany, Company Share by Revenue ($ mn), 2007-2008
Table 17: Clinical Chemistry, Germany, Company Share by Revenue ($ mn), 2007-2008
Table 18: Genetic Testing, Germany, Company Share by Revenue ($ mn), 2007-2008
Table 19: Haematology, Germany, Company Share by Revenue ($ mn), 2007-2008
Table 20: Histology And Cytology, Germany, Company Share by Revenue ($ mn), 2007-2008
Table 21: Immuno Chemistry, Germany, Company Share by Revenue ($ mn), 2007-2008
Table 22: Infectious Immunology, Germany, Company Share by Revenue ($ mn), 2007-2008
Table 23: Microbiology Culture, Germany, Company Share by Revenue ($ mn), 2007-2008
Table 24: In Vitro Diagnostics, France, Overall Revenue ($ mn), 2000-2015
Table 25: In Vitro Diagnostics, France, Overall Revenue ($ mn), Historic, 2000-2008
Table 26: In Vitro Diagnostics, France, Overall Revenue ($ mn), Forecast, 2008-2015
Table 27: Clinical Chemistry, France, Distribution Share by Revenue ($mn), 2007-2008
Table 28: Genetic Testing, France, Distribution Share by Revenue ($mn), 2007-2008
Table 29: Haematology, France, Distribution Share by Revenue ($mn), 2007-2008
Table 30: Histology And Cytology, France, Distribution Share by Revenue ($mn), 2007-2008
Table 31: Immuno Chemistry, France, Distribution Share by Revenue ($mn), 2007-2008
Table 32: Infectious Immunology, France, Distribution Share by Revenue ($mn), 2007-2008
Table 33: Microbiology Culture, France, Distribution Share by Revenue ($mn), 2007-2008
Table 34: In Vitro Diagnostics, France, Company Share by Revenue ($ mn), 2007-2008
Table 35: Clinical Chemistry, France, Company Share by Revenue ($ mn), 2007-2008
Table 36: Genetic Testing, France, Company Share by Revenue ($ mn), 2007-2008
Table 37: Haematology, France, Company Share by Revenue ($ mn), 2007-2008
Table 38: Histology And Cytology, France, Company Share by Revenue ($ mn), 2007-2008
Table 39: Immuno Chemistry, France, Company Share by Revenue ($ mn), 2007-2008
Table 40: Infectious Immunology, France, Company Share by Revenue ($ mn), 2007-2008
Table 41: Microbiology Culture, France, Company Share by Revenue ($ mn), 2007-2008
Table 42: In Vitro Diagnostics, United Kingdom, Overall Revenue ($ mn), 2000-2015
Table 43: In Vitro Diagnostics, United Kingdom, Overall Revenue ($ mn), Historic, 2000-2008
Table 44: In Vitro Diagnostics, United Kingdom, Overall Revenue ($ mn), Forecast, 2008-2015
Table 45: Clinical Chemistry, United Kingdom, Distribution Share by Revenue ($mn), 2007-2008
Table 46: Genetic Testing, United Kingdom, Distribution Share by Revenue ($mn), 2007-2008
Table 47: Haematology, United Kingdom, Distribution Share by Revenue ($mn), 2007-2008
Table 48: Histology And Cytology, United Kingdom, Distribution Share by Revenue ($mn), 2007-2008
Table 49: Immuno Chemistry, United Kingdom, Distribution Share by Revenue ($mn), 2007-2008
Table 50: Infectious Immunology, United Kingdom, Distribution Share by Revenue ($mn), 2007-2008
Table 51: Microbiology Culture, United Kingdom, Distribution Share by Revenue ($mn), 2007-2008
Table 52: In Vitro Diagnostics, United Kingdom, Company Share by Revenue ($ mn), 2007-2008
Table 53: Clinical Chemistry, United Kingdom, Company Share by Revenue ($ mn), 2007-2008
Table 54: Genetic Testing, United Kingdom, Company Share by Revenue ($ mn), 2007-2008
Table 55: Haematology, United Kingdom, Company Share by Revenue ($ mn), 2007-2008
Table 56: Histology And Cytology, United Kingdom, Company Share by Revenue ($ mn), 2007-2008
Table 57: Immuno Chemistry, United Kingdom, Company Share by Revenue ($ mn), 2007-2008
Table 58: Infectious Immunology, United Kingdom, Company Share by Revenue ($ mn), 2007-2008
Table 59: Microbiology Culture, United Kingdom, Company Share by Revenue ($ mn), 2007-2008
Table 60: In Vqitro Diagnostics, Italy, Overall Revenue ($ mn), 2000-2015
Table 61: In Vitro Diagnostics, Italy, Overall Revenue ($ mn), Historic, 2000-2008
Table 62: In Vitro Diagnostics, Italy, Overall Revenue ($ mn), Forecast, 2008-2015
Table 63: Clinical Chemistry, Italy, Distribution Share by Revenue ($mn), 2007-2008
Table 64: Genetic Testing, Italy, Distribution Share by Revenue ($mn), 2007-2008
Table 65: Haematology, Italy, Distribution Share by Revenue ($mn), 2007-2008
Table 66: Histology And Cytology, Italy, Distribution Share by Revenue ($mn), 2007-2008
Table 67: Immuno Chemistry, Italy, Distribution Share by Revenue ($mn), 2007-2008
Table 68: Infectious Immunology, Italy, Distribution Share by Revenue ($mn), 2007-2008
Table 69: Microbiology Culture, Italy, Distribution Share by Revenue ($mn), 2007-2008
Table 70: In Vitro Diagnostics, Italy, Company Share by Revenue ($ mn), 2007-2008
Table 71: Clinical Chemistry, Italy, Company Share by Revenue ($ mn), 2007-2008
Table 72: Genetic Testing, Italy, Company Share by Revenue ($ mn), 2007-2008
Table 73: Haematology, Italy, Company Share by Revenue ($ mn), 2007-2008
Table 74: Histology And Cytology, Italy, Company Share by Revenue ($ mn), 2007-2008
Table 75: Immuno Chemistry, Italy, Company Share by Revenue ($ mn), 2007-2008
Table 76: Infectious Immunology, Italy, Company Share by Revenue ($ mn), 2007-2008
Table 77: Microbiology Culture, Italy, Company Share by Revenue ($ mn), 2007-2008
Table 78: In Vitro Diagnostics, Spain, Overall Revenue ($ mn), 2000-2015
Table 79: In Vitro Diagnostics, Spain, Overall Revenue ($ mn), Historic, 2000-2008
Table 80: In Vitro Diagnostics, Spain, Overall Revenue ($ mn), Forecast, 2008-2015
Table 81: Clinical Chemistry, Spain, Distribution Share by Revenue ($mn), 2007-2008
Table 82: Genetic Testing, Spain, Distribution Share by Revenue ($mn), 2007-2008
Table 83: Haematology, Spain, Distribution Share by Revenue ($mn), 2007-2008
Table 84: Histology And Cytology, Spain, Distribution Share by Revenue ($mn), 2007-2008
Table 85: Immuno Chemistry, Spain, Distribution Share by Revenue ($mn), 2007-2008
Table 86: Infectious Immunology, Spain, Distribution Share by Revenue ($mn), 2007-2008
Table 87: Microbiology Culture, Spain, Distribution Share by Revenue ($mn), 2007-2008
Table 88: In Vitro Diagnostics, Spain, Company Share by Revenue ($ mn), 2007-2008
Table 89: Clinical Chemistry, Spain, Company Share by Revenue ($ mn), 2007-2008
Table 90: Genetic Testing, Spain, Company Share by Revenue ($ mn), 2007-2008
Table 91: Haematology, Spain, Company Share by Revenue ($ mn), 2007-2008
Table 92: Histology And Cytology, Spain, Company Share by Revenue ($ mn), 2007-2008
Table 93: Immuno Chemistry, Spain, Company Share by Revenue ($ mn), 2007-2008
Table 94: Infectiozus Immunology, Spain, Company Share by Revenue ($ mn), 2007-2008
Table 95: Microbiology Culture, Spain, Company Share by Revenue ($ mn), 2007-2008
Table 96: In Vitro Diagnostics, Netherlands, Overall Revenue ($ mn), 2000-2015
Table 97: In Vitro Diagnostics, Netherlands, Overall Revenue ($ mn), Historic, 2000-2008
Table 98: In Vitro Diagnostics, Netherlands, Overall Revenue ($ mn), Forecast, 2008-2015
Table 99: Clinical Chemistry, Netherlands, Distribution Share by Revenue ($mn), 2007-2008
Table 100: Genetic Testing, Netherlands, Distribution Share by Revenue ($mn), 2007-2008
Table 101: Haematology, Netherlands, Distribution Share by Revenue ($mn), 2007-2008
Table 102: Histology And Cytology, Netherlands, Distribution Share by Revenue ($mn), 2007-2008
Table 103: Immuno Chemistry, Netherlands, Distribution Share by Revenue ($mn), 2007-2008
Table 104: Infectious Immunology, Netherlands, Distribution Share by Revenue ($mn), 2007-2008
Table 105: Microbiology Culture, Netherlands, Distribution Share by Revenue ($mn), 2007-2008
Table 106: In Vitro Diagnostics, Netherlands, Company Share by Revenue ($ mn), 2007-2008
Table 107: Clinical Chemistry, Netherlands, Company Share by Revenue ($ mn), 2007-2008
Table 108: Genetic Testing, Netherlands, Company Share by Revenue ($ mn), 2007-2008
Table 109: Haematology, Netherlands, Company Share by Revenue ($ mn), 2007-2008
Table 110: Histology And Cytology, Netherlands, Company Share by Revenue ($ mn), 2007-2008
Table 111: Immuno Chemistry, Netherlands, Company Share by Revenue ($ mn), 2007-2008
Table 112: Infectious Immunology, Netherlands, Company Share by Revenue ($ mn), 2007-2008
Table 113: Microbiology Culture, Netherlands, Company Share by Revenue ($ mn), 2007-2008
Table 114: In Vitro Diagnostics, Belgium, Overall Revenue ($ mn), 2000-2015
Table 115: In Vitro Diagnostics, Belgium, Overall Revenue ($ mn), Historic, 2000-2008
Table 116: In Vitro Diagnostics, Belgium, Overall Revenue ($ mn), Forecast, 2008-2015
Table 117: Clinical Chemistry, Belgium, Distribution Share by Revenue ($mn), 2007-2008
Table 118: Genetic Testing, Belgium, Distribution Share by Revenue ($mn), 2007-2008
Table 119: Haematology, Belgium, Distribution Share by Revenue ($mn), 2007-2008
Table 120: Histology And Cytology, Belgium, Distribution Share by Revenue ($mn), 2007-2008
Table 121: Immuno Chemistry, Belgium, Distribution Share by Revenue ($mn), 2007-2008
Table 122: Infectious Immunology, Belgium, Distribution Share by Revenue ($mn), 2007-2008
Table 123: Microbiology Culture, Belgium, Distribution Share by Revenue ($mn), 2007-2008
Table 124: In Vitro Diagnostics, Belgium, Company Share by Revenue ($ mn), 2007-2008
Table 125: Clinical Chemistry, Belgium, Company Share by Revenue ($ mn), 2007-2008
Table 126: Genetic Testing, Belgium, Company Share by Revenue ($ mn), 2007-2008
Table 127: Haematology, Belgium, Company Share by Revenue ($ mn), 2007-2008
Table 128: Histology And Cytology, Belgium, Company Share by Revenue ($ mn), 2007-2008
Table 129: Immuno Chemistry, Belgium, Company Share by Revenue ($ mn), 2007-2008
Table 130: Infectious Immunology, Belgium, Company Share by Revenue ($ mn), 2007-2008
Table 131: Microbiology Culture, Belgium, Company Share by Revenue ($ mn), 2007-2008
Table 132: Sysmex Corporation Pipeline Products by Equipment Type
Table 133: Sysmex Corporation Pipeline Products By Development Stage
Table 134: Sysmex Corporation Pipeline Products By Therapy Area
Table 135: Qiagen N.V. Pipeline Products by Equipment Type
Table 136: Qiagen N.V. Pipeline Products By Development Stage
Table 137: Qiagen N.V. Pipeline Products By Therapy Area
Table 138: Phadia AB Pipeline Products by Equipment Type
Table 139: Phadia AB Pipeline Products By Development Stage
Table 140: Phadia AB Pipeline Products By Therapy Area
Table 141: Ortho-Clinical Diagnostics Inc. Pipeline Products by Equipment Type
Table 142: Ortho-Clinical Diagnostics Inc. Pipeline Products By Development Stage
Table 143: Ortho-Clinical Diagnostics Inc. Pipeline Products By Therapy Area
Table 144: Ortho-Clinical Diagnostics Inc. Pipeline Products By Clinical Trials
Table 145: Mindray Medical International Limited Pipeline Products by Equipment Type
Table 146: Mindray Medical International Limited Pipeline Products By Development Stage
Table 147: Mindray Medical International Limited Pipeline Products By Therapy Area
Table 148: Inverness Medical Innovations, Inc. Pipeline Products by Equipment Type
Table 149: Inverness Medical Innovations, Inc. Pipeline Products By Development Stage
Table 150: Inverness Medical Innovations, Inc. Pipeline Products By Therapy Area
Table 151: Inverness Medical Innovations, Inc. Pipeline Products By Clinical Trials
Table 152: Hologic, Inc. Pipeline Products by Equipment Type
Table 153: Hologic, Inc. Pipeline Products By Development Stage
Table 154: Hologic, Inc. Pipeline Products By Therapy Area
Table 155: Gen-Probe Incorporated Pipeline Products by Equipment Type
Table 156: Gen-Probe Incorporated Pipeline Products By Development Stage
Table 157: Gen-Probe Incorporated Pipeline Products By Therapy Area
Table 158: Gen-Probe Incorporated Pipeline Products By Clinical Trials
Table 159: DiaSorin S.p.A Pipeline Products by Equipment Type
Table 160: DiaSorin S.p.A Pipeline Products By Development Stage
Table 161: DiaSorin S.p.A Pipeline Products By Therapy Area
Table 162: Biomerieux Sa Pipeline Products by Equipment Type
Table 163: Biomerieux Sa Pipeline Products By Development Stage
Table 164: Biomerieux Sa Pipeline Products By Therapy Area
Table 165: Biomerieux Sa Pipeline Products By Clinical Trials
Table 166: Becton, Dickinson and Company Pipeline Products by Equipment Type
Table 167: Becton, Dickinson and Company Pipeline Products By Development Stage
Table 168: Becton, Dickinson and Company Pipeline Products By Therapy Area
Table 169: Beckman Coulter, Inc. Pipeline Products by Equipment Type
Table 170: Beckman Coulter, Inc. Pipeline Products By Development Stage
Table 171: Beckman Coulter, Inc. Pipeline Products By Therapy Area
Table 172: Abbott Laboratories Pipeline Products by Equipment Type
Table 173: Abbott Laboratories Pipeline Products By Development Stage
Table 174: Abbott Laboratories Pipeline Products By Therapy Area
Table 175: Lab21 Acquires Delphic Diagnostic From BDO
Table 176: International SOS Acquires Majority Stake In Abermed
Table 177: Bio-Rad Laboratories To Acquire Medical Diagnostics Segment From Biotest
Table 178: ERBA DIAGNOSTICS MANNHEIM Acquires PLIVA-Lachema Diagnostika
Table 179: Thermo Fisher Scientific Completes Acquisition Of B.R.A.H.M.S
Table 180: QIAGEN Completes Acquisition Of DxS
Table 181: Legal & General Ventures To Sell LGC
Table 182: LinkMed To Acquire 51% Stake In AbSorber From Koncentra And Jan Holgersson
Table 183: North Atlantic Value Completes Acquisition Of Celsis International
Table 184: The Riverside Acquires Crioestaminal Saude e Tecnologia
Table 185: Curetis Secures $27.89 Million In Series A Round Of Financing
Table 186: Biomedical Diagnostics Secures $4.52 Million In Financing
Table 187: Pronota Secures Additional $1.92 Million In Series B Round Of Financing
Table 188: Biocartis Secures $14.9 Million In Series A Equity Round Of Financing
Table 189: mtm laboratories Secures $10.21 Million In Fourth Tranche Of Series C Financing Round
Table 190: Kreatech Diagnostics Secures $2.86 Million In Financing Round
Table 191: Agendia Raises $23 Million In Series E Financing
Table 192: ExonHit Therapeutics Plans Rights Issue Of New Shares For $25.67 Million
Table 193: Osmetech Announces Private Placement Of Shares For $16.3 Million
Table 194: Mediwatch Completes Private Placement Of $0.57 Million
Table 195: QIAGEN Completes Private Placement Of Its Common Stock For $640 Million
Table 196: HairDX Enters Into Distribution Agreement With Svenson Haar Studios
Table 197: MabCure Signs Research Agreement With AZ Sint-Lucas
Table 198: USD to Local Currency, Average Exchange Rate 2008
1.2 List of Figures
Figure 1: In Vitro Diagnostics, Europe, Overall Revenue ($ mn), 2000-2015
Figure 2: Europe In Vitro Diagnostics Market, Cross-Category Analysis, 2000-2015
Figure 3: In Vitro Diagnostics, Europe, Overall Revenue ($ mn), Historic, 2000-2008
Figure 4: In Vitro Diagnostics, Europe, Overall Revenue ($ mn), Forecast, 2008-2015
Figure 5: In Vitro Diagnostics, Europe, Company share (%), 2008
Figure 6: In Vitro Diagnostics, Germany, Overall Revenue ($ mn), 2000-2015
Figure 7: In Vitro Diagnostics, Germany, Overall Revenue ($ mn), Historic, 2000-2008
Figure 8: In Vitro Diagnostics, Germany, Overall Revenue ($ mn), Forecast, 2008-2015
Figure 9: In Vitro Diagnostics, Germany, Company Share (%), 2008
Figure 10: Clinical Chemistry, Germany, Company Share (%), 2008
Figure 11: Genetic Testing, Germany, Company Share (%), 2008
Figure 12: Haematology, Germany, Company Share (%), 2008
Figure 13: Histology And Cytology, Germany, Company Share (%), 2008
Figure 14: Immuno Chemistry, Germany, Company Share (%), 2008
Figure 15: Infectious Immunology, Germany, Company Share (%), 2008
Figure 16: Microbiology Culture, Germany, Company Share (%), 2008
Figure 17: In Vitro Diagnostics, France, Overall Revenue ($ mn), 2000-2015
Figure 18: In Vitro Diagnostics, France, Overall Revenue ($ mn), Historic, 2000-2008
Figure 19: In Vitro Diagnostics, France, Overall Revenue ($ mn), Forecast, 2008-2015
Figure 20: In Vitro Diagnostics, France, Company Share (%), 2008
Figure 21: Clinical Chemistry, France, Company Share (%), 2008
Figure 22: Genetic Testing, France, Company Share (%), 2008
Figure 23: Haematology, France, Company Share (%), 2008
Figure 24: Histology And Cytology, France, Company Share (%), 2008
Figure 25: Immuno Chemistry, France, Company Share (%), 2008
Figure 26: Infectious Immunology, France, Company Share (%), 2008
Figure 27: Microbiology Culture, France, Company Share (%), 2008
Figure 28: In Vitro Diagnostics, United Kingdom, Overall Revenue ($ mn), 2000-2015
Figure 29: In Vitro Diagnostics, United Kingdom, Overall Revenue ($ mn), Historic, 2000-2008
Figure 30: In Vitro Diagnostics, United Kingdom, Overall Revenue ($ mn), Forecast, 2008-2015
Figure 31: In Vitro Diagnostics, United Kingdom, Company Share (%), 2008
Figure 32: Clinical Chemistry, United Kingdom, Company Share (%), 2008
Figure 33: Genetic Testing, United Kingdom, Company Share (%), 2008
Figure 34: Haematology, United Kingdom, Company Share (%), 2008
Figure 35: Histology And Cytology, United Kingdom, Company Share (%), 2008
Figure 36: Immuno Chemistry, United Kingdom, Company Share (%), 2008
Figure 37: Infectious Immunology, United Kingdom, Company Share (%), 2008
Figure 38: Microbiology Culture, United Kingdom, Company Share (%), 2008
Figure 39: In Vitro Diagnostics, Italy, Overall Revenue ($ mn), 2000-2015
Figure 40: In Vitro Diagnostics, Italy, Overall Revenue ($ mn), Historic, 2000-2008
Figure 41: In Vitro Diagnostics, Italy, Overall Revenue ($ mn), Forecast, 2008-2015
Figure 42: In Vitro Diagnostics, Italy, Company Share (%), 2008
Figure 43: Clinical Chemistry, Italy, Company Share (%), 2008
Figure 44: Genetic Testing, Italy, Company Share (%), 2008
Figure 45: Haematology, Italy, Company Share (%), 2008
Figure 46: Histology And Cytology, Italy, Company Share (%), 2008
Figure 47: Immuno Chemistry, Italy, Company Share (%), 2008
Figure 48: Infectious Immunology, Italy, Company Share (%), 2008
Figure 49: Microbiology Culture, Italy, Company Share (%), 2008
Figure 50: In Vitro Diagnostics, Spain, Overall Revenue ($ mn), 2000-2015
Figure 51: In Vitro Diagnostics, Spain, Overall Revenue ($ mn), Historic, 2000-2008
Figure 52: In Vitro Diagnostics, Spain, Overall Revenue ($ mn), Forecast, 2008-2015
Figure 53: In Vitro Diagnostics, Spain, Company Share (%), 2008
Figure 54: Clinical Chemistry, Spain, Company Share (%), 2008
Figure 55: Genetic Testing, Spain, Company Share (%), 2008
Figure 56: Haematology, Spain, Company Share (%), 2008
Figure 57: Histology And Cytology, Spain, Company Share (%), 2008
Figure 58: Immuno Chemistry, Spain, Company Share (%), 2008
Figure 59: Infectious Immunology, Spain, Company Share (%), 2008
Figure 60: Microbiology Culture, Spain, Company Share (%), 2008
Figure 61: In Vitro Diagnostics, Netherlands, Overall Revenue ($ mn), 2000-2015
Figure 62: In Vitro Diagnostics, Netherlands, Overall Revenue ($ mn), Historic, 2000-2008
Figure 63: In Vitro Diagnostics, Netherlands, Overall Revenue ($ mn), Forecast, 2008-2015
Figure 64: In Vitro Diagnostics, Netherlands, Company Share (%), 2008
Figure 65: Clinical Chemistry, Netherlands, Company Share (%), 2008
Figure 66: Genetic Testing, Netherlands, Company Share (%), 2008
Figure 67: Haematology, Netherlands, Company Share (%), 2008
Figure 68: Histology And Cytology, Netherlands, Company Share (%), 2008
Figure 69: Immuno Chemistry, Netherlands, Company Share (%), 2008
Figure 70: Infectious Immunology, Netherlands, Company Share (%), 2008
Figure 71: Microbiology Culture, Netherlands, Company Share (%), 2008
Figure 72: In Vitro Diagnostics, Belgium, Overall Revenue ($ mn), 2000-2015
Figure 73: In Vitro Diagnostics, Belgium, Overall Revenue ($ mn), Historic, 2000-2008
Figure 74: In Vitro Diagnostics, Belgium, Overall Revenue ($ mn), Forecast, 2008-2015
Figure 75: In Vitro Diagnostics, Belgium, Company Share (%), 2008
Figure 76: Clinical Chemistry, Belgium, Company Share (%), 2008
Figure 77: Genetic Testing, Belgium, Company Share (%), 2008
Figure 78: Haematology, Belgium, Company Share (%), 2008
Figure 79: Histology And Cytology, Belgium, Company Share (%), 2008
Figure 80: Immuno Chemistry, Belgium, Company Share (%), 2008
Figure 81: Infectious Immunology, Belgium, Company Share (%), 2008
Figure 82: Microbiology Culture, Belgium, Company Share (%), 2008
Figure 83: Global Markets Direct Methodology
- Ventana Medical Systems, Inc.
- Sysmex Corporation
- Siemens Healthcare
- Qiagen N.V.
- Phadia AB
- Ortho-Clinical Diagnostics Inc.
- Mindray Medical International Limited
- Inverness Medical Innovations, Inc.
- Hologic, Inc.
- Gen-Probe Incorporated
- F. Hoffmann-La Roche Ltd.
- Digene Corporation
- Dade Behring Holdings, Inc.
- DiaSorin S.p.A
- Bio-Rad Laboratories, Inc.
- bioMerieux S.A.
- Becton, Dickinson and Company
- Beckman Coulter, Inc.
- Abbott Laboratories
Customers who bought this item also bought
All rights reserved. © Copyright 2013 Research and Markets WWW4
Terms and Conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster Affiliate Network
